Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study
Abstract Introduction Atopic dermatitis (AD) is a chronic disease that occurs mainly in children. Topical corticosteroids are the main treatment for mild to moderate AD, although they can induce side effects. The efficacy and tolerability of xyloglucan and pea protein (XG-PP) was compared with hydro...
Main Authors: | Mehdi Sowlati, Silviu-Horia Morariu, Olguta Orzan, Stefano Veraldi, Roni P. Dodiuk-Gad, Remus I. Orasan, Cristian Gainaru |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-09-01
|
Series: | Dermatology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s13555-023-01035-6 |
Similar Items
-
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis
by: Michela Campolo, et al.
Published: (2020-05-01) -
Evaluation of the Efficacy of Xyloglucan, Pea Protein and <i>Opuntia ficus-indica</i> Extract in a Preclinical Model of Psoriasis
by: Alessia Filippone, et al.
Published: (2023-02-01) -
Real-life efficiency and safety comparison study of emollient ointment based on glycerophosphoinositol (GPI) salt of choline and other emollient products in patients with atopic dermatitis
by: Monika Marko, et al.
Published: (2022-02-01) -
In situ mucoadhesive hydrogel based on methylcellulose/xyloglucan for periodontitis : graphical abstract
by: Hirun, Namon, et al.
Published: (2020) -
Commentary: A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children
by: Jane Harvey, et al.
Published: (2024-02-01)